Lorenzo M, Fernández-Veledo S, Vila-Bedmar R, Garcia-Guerra L, De Alvaro C, Nieto-Vazquez I
Departamento de Bioquimica y Biologia Molecular II, Facultad de Farmacia, Universidad Complutense, 28040-Madrid, Spain.
J Anim Sci. 2008 Apr;86(14 Suppl):E94-104. doi: 10.2527/jas.2007-0462. Epub 2007 Oct 16.
Insulin resistance is an important contributor to the pathogenesis of type 2 diabetes, and obesity is a risk factor for its development, in part because adipose tissue secretes proteins, called adipokines, that may influence insulin sensitivity. Among these molecules, tumor necrosis factor (TNF)-alpha has been proposed as a link between obesity and insulin resistance because TNF-alpha is overexpressed in adipose tissues of obese animals and humans, and obese mice lacking either TNF-alpha or its receptor show protection against developing insulin resistance. Direct exposure to TNF-alpha induces a state of insulin resistance in terms of glucose uptake in myocytes and brown adipocytes because of the activation of proinflammatory pathways that impair insulin signaling at the level of the insulin receptor substrate (IRS) proteins. In this regard, the Ser(307) residue in IRS-1 has been identified as a site for the inhibitory effects of TNF-alpha in myotubes, with p38 mitogen-activated protein kinase and inhibitor kB kinase being involved in the phosphorylation of this residue. Conversely, Ser phosphorylation of IRS-2 mediated by TNF-alpha activation of mitogen-activated protein kinase was the mechanism found in brown adipocytes. Protein-Tyr phosphatase (PTP)1B acts as a physiological, negative regulator of insulin signaling by dephosphorylating the phosphotyrosine residues of the insulin receptor and IRS-1, and PTP1B expression is increased in muscle and white adipose tissue of obese and diabetic humans and rodents. Moreover, up-regulation of PTP1B expression was recently found in cells treated with TNF-alpha Accordingly, myocytes and primary brown adipocytes deficient in PTP1B are protected against insulin resistance induced by this cytokine. Furthermore, down-regulation of PTP1B activity is possible by the use of pharmacological agonists of nuclear receptors that restore insulin sensitivity in the presence of TNF-alpha. In conclusion, the lack of PTP1B in muscle and brown adipocytes increases insulin sensitivity and glucose uptake and could confer protection against insulin resistance induced by adipokines.
胰岛素抵抗是2型糖尿病发病机制的重要促成因素,肥胖是其发生发展的一个危险因素,部分原因是脂肪组织分泌的蛋白质(称为脂肪因子)可能影响胰岛素敏感性。在这些分子中,肿瘤坏死因子(TNF)-α被认为是肥胖与胰岛素抵抗之间的一个联系纽带,因为TNF-α在肥胖动物和人类的脂肪组织中过度表达,并且缺乏TNF-α或其受体的肥胖小鼠对胰岛素抵抗的发生具有保护作用。直接暴露于TNF-α会在肌细胞和棕色脂肪细胞的葡萄糖摄取方面诱导一种胰岛素抵抗状态,这是由于促炎途径的激活,该途径在胰岛素受体底物(IRS)蛋白水平损害胰岛素信号传导。在这方面,IRS-1中的Ser(307)残基已被确定为TNF-α在肌管中产生抑制作用的位点,p38丝裂原活化蛋白激酶和IκB激酶参与该残基的磷酸化。相反,由TNF-α激活丝裂原活化蛋白激酶介导的IRS-2的丝氨酸磷酸化是在棕色脂肪细胞中发现的机制。蛋白酪氨酸磷酸酶(PTP)1B通过使胰岛素受体和IRS-1的磷酸酪氨酸残基去磷酸化而作为胰岛素信号传导的生理性负调节因子,并且在肥胖和糖尿病的人类及啮齿动物的肌肉和白色脂肪组织中PTP1B表达增加。此外,最近发现在用TNF-α处理的细胞中PTP1B表达上调。因此,缺乏PTP1B的肌细胞和原代棕色脂肪细胞对由这种细胞因子诱导的胰岛素抵抗具有保护作用。此外,通过使用核受体的药理学激动剂可以下调PTP1B活性,这些激动剂在存在TNF-α的情况下可恢复胰岛素敏感性。总之,肌肉和棕色脂肪细胞中缺乏PTP1B可增加胰岛素敏感性和葡萄糖摄取,并可对由脂肪因子诱导的胰岛素抵抗提供保护。